HAPPE Spine Reaches 1,000 Patients with the INTEGRATE®-C Interbody Fusion System
GRAND RAPIDS, Mich., Nov. 13, 2025 /PRNewswire/ — HAPPE Spine, an early stage company advancing clinical outcomes with a proprietary biomaterial and manufacturing platform for creating bone-integrating implants, announces that the INTEGRATE®-C Interbody Fusion System has been implanted in more than 1,000 patients, demonstrating clinical adoption of the HAPPE® platform across more than 30 surgeon users and 40 facilities nationwide.
